MMP 2200

Known as: MMP-2200, MMP2200 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2008-2015
01220082015

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Previous work in our laboratories provides preclinical evidence that mixed-action delta/mu receptor glycopeptides have equivalent… (More)
Is this relevant?
2012
2012
Endogenous opioid peptides enkephalin and dynorphin are major co-transmitters of striatofugal pathways of the basal ganglia. They… (More)
Is this relevant?
2011
2011
We have previously reported the chemistry and antinociceptive properties of a series of glycosylated enkephalin analogs… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
2011
2011
In Parkinson's disease (PD), the consequence of dopaminergic denervation is an imbalance in the activity of the direct and… (More)
Is this relevant?
2008
2008
H2N-Tyr-D-Thr-Gly-Phe-Leu-Ser-(O-D-lactose)-CONH2 (MMP2200) is a novel glycopeptide opioid agonist with similar affinities for… (More)
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2008
2008
H(2)N-Tyr-D-Thr-Gly-Phe-Leu-Ser-(O-beta-D-lactose)-CONH(2) (MMP2200) is a novel glycopeptide opioid agonist with similar… (More)
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?